Targeting angiopoietinâlike 3 in atherosclerosis: From bench to bedside
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes"
DOI: 10.1111/dom.14450
Abstract: Atherosclerotic cardiovascular disease (ASCVD) is the largest cause of morbidity and mortality worldwide. Lipidâlowering therapies are the current major cornerstone of ASCVD management. Statins, ezetimibe, fibrates and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors effectively… read more here.
Keywords: atherosclerosis bench; like atherosclerosis; targeting angiopoietin; bench bedside ... See more keywords
The Role of Colchicine in Atherosclerosis: From Bench to Bedside
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14071395
Abstract: Inflammation is a key feature of atherosclerosis. The inflammatory process is involved in all stages of disease progression, from the early formation of plaque to its instability and disruption, leading to clinical events. This strongly… read more here.
Keywords: colchicine atherosclerosis; bench bedside; atherosclerosis bench; colchicine ... See more keywords